Methodological constraints in interpreting serum paraoxonase-1 activity measurements: An example from a study in HIV-infected patients

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Parra, Sandra ^a   Marsillach, Judit ^a   Aragonès, Gerard ^a   Rull, Anna ^a   Beltrán Debón, Raúl ^a   Alonso Villaverde, Carlos ^a   Joven, Jorge ^a   Camps, Jordi ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE 1; BUTYROLACTONE; C REACTIVE PROTEIN; ESTERASE; GLUCONOLACTONASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PARAOXON; ARYLDIALKYLPHOSPHATASE; CCL2 PROTEIN, HUMAN; LACTONE; OXYGEN; PON1 PROTEIN, HUMAN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; BIOSYNTHESIS; BLOOD; CHEMISTRY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; INFLAMMATION; METABOLISM; METHODOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

APOLIPOPROTEIN A-I; ARYLDIALKYLPHOSPHATASE; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHOLESTEROL, HDL; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HUMANS; INFLAMMATION; LACTONES; OXYGEN; PARAOXON; RESEARCH DESIGN;

EID: 77950987272     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-32     Document Type: Article

References (10)

1. The paraoxonases: role in human diseases and methodological difficulties in measurement. J Camps J Marsillach J Joven, Crit Rev Clin Lab Sci 2009 46 83 96
2. Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. C Alonso-Villaverde B Coll S Parra M Montero N Calvo M Tous J Joven L Masana, Circulation 2004 110 2204 2209 (Pubitemid 39372502)
3. Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection. S Parra C Alonso-Villaverde B Coll N Ferré J Marsillach G Aragonès M Mackness L Masana J Joven J Camps, Atherosclerosis 2007 194 175 81 (Pubitemid 47464297)
4. Paraoxonase-1 gene haplotypes are related to metabolic disturbances, atherosclerosis and immunologic outcome in HIV-infected patients. S Parra J Marsillach G Aragonés R Béte;n M Montero B Coll B Mackness M Mackness C Alonso-Villaverde J Joven J Camps, J Infect Dis 2010 201 627 634
5. The role of immunity in the progression of atherosclerosis in patients with HIV infection. B Coll S Parra C Alonso-Villaverde G Aragonès M Montero J Camps J Joven L Masana, Stroke 2007 38 2477 2484 (Pubitemid 47329625)
6. The human serum paraoxonase/arylesterase polymorphism. HW Eckerson CM Wyte BN La Du, Am J Hum Genet 1983 35 1126 1138
7. The development of human sera test for HDL-bound serum PON1 and its lipolactonase activity. L Gaidukov DS Tawfik, J Lipid Res 2007 48 1637 1646 (Pubitemid 47312025)
8. The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. J Marsillach G Aragonès R Beltrán J Caballeria J Pedro-Botet C Morcillo-Suárez A Navarro J Joven J Camps, Clin Biochem 2009 42 918
9. The double jeopardy of HDL. M Navab GM Ananthramaiah ST Reddy BJ Van Lenten BJ Ansell S Hama G Hough E Bachini VR Grijalva AC Wagner Z Shaposhnik AM Fogelman, Ann Med 2005 37 173 78 (Pubitemid 40780434)
10. Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. J Marsillach B Mackness M Mackness F Riu R Beltrán Joven J Camps, Free Rad Biol Med 2008 45 146 157 10.1